Assessing Health Needs of the Burlington Probation and Parole Population

The Burlington Probation and Parole population confronts numerous social, economic, and healthcare challenges upon their return to the community. While health and healthcare issues of inmates have been studied extensively, the health status and medical issues of the reentry offenders, particularly in rural areas have not been previously assessed. Data about health risks, major medical issues, and lifestyle choices among offenders on parole in the rural setting may prove helpful in the identification of preventative measures and development of strategies to promote positive health behaviors among the target population. The aim of this study is to evaluate the health risks among offenders on parole in the Burlington area and guide recommendations towards improving their health outcomes through community and educational initiatives. We also sought to gain a better understanding of the barriers within the rural setting that prevent positive health behaviors among the parolees upon their reintegration into the communityhttps://scholarworks.uvm.edu/comphp_gallery/1068/thumbnail.jp

Open surgical ligation of a symptomatic mycotic aneurysm of the peroneal artery

A mycotic peroneal artery aneurysm (MPAA) is a rare diagnosis. We describe a case of a patient with active fungal endocarditis who developed right lower extremity pain. Imaging demonstrated that this patient had an MPAA. This was treated with open ligation of the peroneal artery, and decompression of the aneurysm sac was performed for symptom relief. Although a rare diagnosis, MPAA should be considered in patients with a history of endocarditis who present with leg pain. Keywords: Infected aneurysm, Pseudoaneurysm, Infrainguinal, Endocarditi

Recanalization of previously thrombosed type II endoleak with aneurysm sac expansion after systemic thrombolysis

Patients who have undergone endovascular aneurysm repair (EVAR) need lifelong monitoring because of the risk of aneurysm rupture secondary to delayed endoleaks. Thrombolytic therapy may expose patients with previous EVAR to the risk for development of new endoleaks. We describe a case in which a single dose of intravenous tissue plasminogen activator for acute ischemic stroke was complicated by aneurysm sac expansion secondary to a recurrent endoleak. The potential for a life-threatening complication may warrant routine imaging evaluation of the stent graft after systemic tissue plasminogen activator therapy for acute ischemic stroke in patients with previous EVAR. Keywords: AAA, EVAR, Endoleak, Acute ischemic stroke, Thrombolytic therapy, tP